| Entry |
|
|---|
| Name |
Dipyridamole (JP18/USP/INN);
Persantine (TN) |
|---|
| Product |
|
|---|
| Generic |
|
|---|
| Formula |
C24H40N8O4
|
|---|
| Exact mass |
504.3173
|
|---|
| Mol weight |
504.63
|
|---|
| Structure |
|
|---|
| Class |
Cardiovascular agent
DG01509 Phosphodiesterase V inhibitor
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
|
|---|
| Remark |
| Therapeutic category: | 2171 |
| Product (mixture): | D11615<US> |
|
|---|
| Efficacy |
Vasodilator (coronary), Platelet aggregation inhibitor, Phosphodiesterase inhibitor |
|---|
| Comment |
Pyrimido-pyrimidine derivative
|
|---|
| Target |
|
|---|
| Pathway |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
B BLOOD AND BLOOD FORMING ORGANS
B01 ANTITHROMBOTIC AGENTS
B01A ANTITHROMBOTIC AGENTS
B01AC Platelet aggregation inhibitors excl. heparin
B01AC07 Dipyridamole
D00302 Dipyridamole (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Blood Products and Modifiers
Platelet Modifying Agents
Platelet Modifying Agents, Other
Dipyridamole
D00302 Dipyridamole (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
217 Vasodilators
2171 Coronary dilators
D00302 Dipyridamole (JP18/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01509 Phosphodiesterase V inhibitor
D00302 Dipyridamole
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
D00302 Dipyridamole
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE4A
D00302 Dipyridamole (JP18/USP/INN) <JP/US>
PDE5
D00302 Dipyridamole (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00302 Dipyridamole
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 36
1 C8y C 21.7700 -17.7144
2 C8y C 21.7700 -16.3056
3 C8y C 20.5532 -18.4130
4 N5x N 22.9868 -18.4130
5 C8y C 22.9868 -15.6127
6 N5x N 20.5532 -15.6127
7 N1y N 20.5532 -19.8103
8 N5x N 19.3423 -17.7144
9 C8y C 24.1919 -17.7144
10 N1y N 22.9868 -14.2097
11 N5x N 24.1919 -16.3056
12 C8y C 19.3423 -16.3056
13 C1x C 19.3423 -20.5089
14 C1x C 21.7700 -20.5089
15 N1c N 25.4087 -18.4073
16 C1x C 24.2036 -13.5111
17 C1x C 21.7757 -13.5052
18 N1c N 18.1313 -15.6127
19 C1x C 19.3423 -21.9121
20 C1x C 21.7700 -21.9121
21 C1b C 25.4087 -19.8103
22 C1b C 26.6139 -17.7086
23 C1x C 24.2036 -12.1079
24 C1x C 21.7757 -12.1079
25 C1b C 18.1313 -14.2097
26 C1b C 16.9204 -16.3056
27 C1x C 20.5532 -22.6048
28 C1b C 26.6139 -20.5148
29 C1b C 27.8306 -18.4073
30 C1x C 22.9925 -11.4152
31 C1b C 16.9204 -13.5052
32 C1b C 15.7094 -15.6127
33 O1a O 27.8306 -19.8103
34 O1a O 29.0415 -17.7027
35 O1a O 15.7094 -14.2097
36 O1a O 14.4985 -16.3056
BOND 39
1 1 2 2
2 1 3 1
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 2
8 4 9 2
9 5 10 1
10 5 11 2
11 6 12 2
12 7 13 1
13 7 14 1
14 9 15 1
15 10 16 1
16 10 17 1
17 12 18 1
18 13 19 1
19 14 20 1
20 15 21 1
21 15 22 1
22 16 23 1
23 17 24 1
24 18 25 1
25 18 26 1
26 19 27 1
27 21 28 1
28 22 29 1
29 23 30 1
30 25 31 1
31 26 32 1
32 28 33 1
33 29 34 1
34 31 35 1
35 32 36 1
36 8 12 1
37 9 11 1
38 20 27 1
39 24 30 1
|
|---|
